Company: CRAC
Filing Date: 2025-10-20
Form Type: POS462C
Source: 0001213900-25-100119
Chunk: 117

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-10-20
Form: POS462C
Chunk 117
---
 no exercise of the underwriters’ over -allotmentoption), the difference between the pro forma net tangible book value per share of $7.45 and the initial offering price of $10.00 per unit. This dilution would increase to the extent that the anti -dilutionprovisions of the Class B ordinary shares result in the issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion of the Class B ordinary shares at the time of our initial business combination. In addition, because of the anti -dilutionprotection in the founder shares, any equity or equity -linkedsecurities issued or deemed issued in connection with our initial business combination would be disproportionately dilutive to our Class A ordinary shares. This dilution would be exacerbated to the extent other public shareholders seek redemptions from the trust. Since our sponsor paid only approximately $0.006 per share for the founder shares, certain of our officers and directors could potentially make a substantial profit even if we acquire a target business that subsequently declines in value. On May 12, 2025, our sponsor paid $25,000 to cover certain offering costs in exchange for 4,312,500 founder shares. Up to 562,500 founder shares are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over -allotmentoption is exercised. If none of the founder shares are forfeited, the resulting purchase price 72

would be approximately $0.006 per share. Certain of our officers and directors have a significant economic interest in our sponsor. As a result, the low acquisition cost of the founder shares creates an economic incentive whereby our officers and directors could potentially make a substantial profit even if we complete a business combination with a target business that subsequently declines in value and is unprofitable for public investors. The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination. We are offering our units at an offering price of $10.00 per unit and the amount in our trust account is initially anticipated to be $10.00 per public share, implying an initial value of $10.00 per public share. However, prior to this offering, our sponsor paid a nominal aggregate purchase price of $25,000 for the founder shares, or approximately $0.006 per share. As a result, the value of your public shares may be significantly diluted upon the consum